Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands		3 Months Ended
		Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
Research and development		$ 617	$ 2,726
General and administrative		1,403	3,680
Total operating expenses		2,020	6,406
Loss from operations		(2,020)	(6,406)
Other (expense) income:
Gain on sale of assets		500	0
Interest income		0	48
Interest Expense		(55)	(42)
Change in fair value of rights from Private Placement		0	(3,832)
Other income (expense), net		0	(17)
Total other (expense) income, net		445	(3,843)
Net loss		(1,575)	(10,249)
Net income (loss) attributable to noncontrolling interest		101	(11)
Net loss attributable to Kineta, Inc.		$ (1,676)	$ (10,238)
Net loss per share, basic		$ (0.13)	$ (0.87)
Net loss per share, diluted		$ (0.13)	$ (0.87)
Weighted-average shares outstanding, basic	[1]	12,902	11,738
Weighted-average shares outstanding, diluted	[1]	12,902	11,738

[1] Included in the denominator were 331,000 weighted-average shares of common stock warrants for the three months ended March 31, 2025, with a range of exercise prices of $.001 to $0.14. Included in the denominator were 663,000 weighted-average shares of common stock warrants for the three months ended March 31, 2024, with an exercise price of $0.14.